p185neu is expressed in yolk sac during rat postimplantation development.

We have shown that the neu oncogene product (p185neu) is not present in the rat embryo before organogenesis. However, coincident with the onset of organogenesis, p185neu was detected in neural and connective tissue as well as in the secretory epithelium as was described by Kokai et al. (1987). In addition, p185neu is also expressed in the rat visceral yolk sac (VYS) endodermal cells but not in the mesenchymal and mesothelial layers of the same structure nor in the amnion. The first detectable sign of p185neu expression in VYS was found at d 11 of gestation and the levels of protein increased towards the end of pregnancy. In the yolk sac carcinoma (YSC), which is considered to be the malignant counterpart of the rat yolk sac, p185neu was observed only within columnar epithelial cells (the visceral component of the neoplasm) while parietal endoderm-like cells were devoid of detectable protein. From d 9 of pregnancy up to delivery some of the trophoblastic giant cells also showed a faint to moderate immunoreactivity. Results are presented which would indicate a possible role of p185neu in rat embryogenesis.

[1]  D. Goeddel,et al.  Identification of Heregulin, a Specific Activator of p185erbB2 , 1992, Science.

[2]  K. Pavelić,et al.  Growth factors and proto-oncogenes in early mouse embryogenesis and tumorigenesis. , 1991, The International journal of developmental biology.

[3]  V. Knezević,et al.  Development of separated germ layers of rodent embryos on ectopic sites: a reappraisal. , 1991, The International journal of developmental biology.

[4]  Y. Yarden,et al.  Biochemical analysis of the ligand for the neu oncogenic receptor. , 1991, Biochemistry.

[5]  Takuma Sasaki,et al.  Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer. , 1991, Cancer research.

[6]  R. Lupu,et al.  Direct interaction of a ligand for the erbB2 oncogene product with the EGF receptor and p185erbB2. , 1990, Science.

[7]  W. Jollie Development, morphology, and function of the yolk-sac placenta of laboratory rodents. , 1990, Teratology.

[8]  P. Quirke,et al.  Pattern of expression of c-erbB-2 oncoprotein in human fetuses. , 1989, British Journal of Cancer.

[9]  J. Cohen,et al.  Stage- and tissue-specific expression of the neu oncogene in rat development. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[10]  W. McGuire,et al.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.

[11]  J. Yokota,et al.  AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO , 1986, The Lancet.

[12]  P. Seeburg,et al.  Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. , 1985, Science.

[13]  K. Pavelić,et al.  c-erbB-2/neu in colorectal carcinoma: a potential prognostic value? , 1992, European journal of cancer.

[14]  H. Preisler,et al.  Immunohistochemical detection of c-myc oncoprotein in paraffin embedded tissues. , 1990, Journal of experimental pathology.

[15]  W. Gullick,et al.  c‐erbB‐2 oncoprotein expression in primary human tumors , 1990, Cancer.

[16]  R. Lambson,et al.  An electron microscopic visualization of transport across rat visceral yolk sac. , 1966, The American journal of anatomy.